A DOUBLE BLIND, CROSS OVER, PLACEBO-CONTROLLED, PHASE II TRIAL OF SATIVEX IN HUNTINGTON'S DISEASE - Caldentey, J G; Lopez-Sendon, J L; Trigo, P; Ruiz, C; Ribas, G G; Aguilar, M; Galvez, M A; Pablo, I; Galve-Roth, I; Sagredo, O; Fernandez-Ruiz, J J; Guzman, M; et al. (JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012)